United States:
The Future Of Cannabis And Psilocybin As Plant-Based Medicine: A Conversation With Stephen Dahmer And Betty Aldworth (Podcast)
20 August 2021
Perkins Coie LLP
To print this article, all you need is to be registered or login on Mondaq.com.
Millions of Americans are utilizing medical cannabis and
psilocybin to treat specific medical conditions each day. However,
scientific and medical research lags in the U.S. lags behind other
nations. Dr. Stephen M. Dahmer, Chief Medical Officer at Vireo
Health, and Betty Aldworth, Director of Communications and Events
at the Multidisciplinary Association for Psychedelic Studies (MAPS)
join Perkins Coie senior counsel Andrew Kline to discuss the
current dilemma and a path forward. During the podcast, the group
discusses the current state of cannabis and psilocybin research,
the barriers faced by researchers, and why it is critically
important to have people who understand the science involved in
policymaking.
Listen to "The Future of Cannabis and
Psilocybin as Plant-Based Medicine: A Conversation with Stephen
Dahmer and Betty Aldworth - Episode 13" on Spreaker.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Cannabis & Hemp from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.